CD30+ Lymphoproliferative Disorders of the Skin. - Wikidata - wikimedia - TriplyDB

CD30+ Lymphoproliferative Disorders of the Skin.

CD30+ Lymphoproliferative Disorders of the Skin.

http://www.wikidata.org/entity/Q30235097

about

CD30+ Lymphoproliferative Disorders of the Skin.

http://www.wikidata.org/entity/Q30235097

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

CD30+ Lymphoproliferative Disorders of the Skin.

@ast

CD30+ Lymphoproliferative Disorders of the Skin.

@en

type

label

CD30+ Lymphoproliferative Disorders of the Skin.

@ast

CD30+ Lymphoproliferative Disorders of the Skin.

@en

prefLabel

CD30+ Lymphoproliferative Disorders of the Skin.

@ast

CD30+ Lymphoproliferative Disorders of the Skin.

@en

P1433

Q30235097-63B4ED6A-A71D-47AC-B7B7-8D7E6012AC70

P1476

Q30235097-D420E0C6-B742-4BBA-87C3-129D295E1077

P2093

Q30235097-99AF50BE-CE08-44A9-9008-30677ACFDFA4

Q30235097-B954BAB6-8E7B-4018-89D3-3EA2BC94F59C

Q30235097-F138E287-2699-4201-9F00-794479E3D357

P2860

Q30235097-0E350019-0DA4-4C38-AE46-84E64716E79D

Q30235097-0EB9E54D-8BD8-440A-B2BD-06282C59A8EF

Q30235097-1BE887FD-3BF4-40D9-A0F2-4CB827C59DFA

Q30235097-1C449D22-EF8D-499D-9CB9-F39900AF5E08

Q30235097-240B99AB-D838-4AFF-B513-F64B648F389E

Q30235097-255F7BAB-1863-41F9-86FD-7F9BA0BC3D7B

Q30235097-27DEABDF-D260-4DE9-AF8A-5FBEA25E3AD8

Q30235097-2A0E0E34-B80B-4CD3-9209-A944CE893F4C

Q30235097-2A34CD2C-04E1-4204-850B-D02C2D2FFB8A

Q30235097-3C80A367-090F-4E57-9010-60AA7DA4F620

P304

Q30235097-09789D95-67C9-4B6D-8C2C-AC8691B0A255

P31

Q30235097-BE9A7F33-32FD-4B5A-8A68-34F0C0CFD206

P356

Q30235097-D0BF4FE4-2952-42FF-92D0-051AF9E110C9

P433

Q30235097-70668746-51B1-4357-8910-D189E43A203B

P478

Q30235097-37B25308-EC3B-41FF-ACB8-7016783F9B31

P577

Q30235097-CCCB30D9-6234-469D-B058-97B9BCE6B605

P698

Q30235097-15E61152-B377-49D7-B1AC-1A001F3A4D45

P932

Q30235097-20CFBEF3-23BB-4A15-A663-0B63146B27FE

P356

J.HOC.2016.11.006

P1433

Hematology / Oncology Clinics of North America

P1476

CD30+ Lymphoproliferative Disorders of the Skin.

@en

P2093

John T O'Malley

http://www.w3.org/2001/XMLSchema#string

Maxwell B Sauder

http://www.w3.org/2001/XMLSchema#string

Nicole R LeBoeuf

http://www.w3.org/2001/XMLSchema#string

P2860

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

CD30: from basic research to cancer therapy

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant

Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

WHO-EORTC classification for cutaneous lymphomas.

Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

P304

317-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HOC.2016.11.006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28340881

http://www.w3.org/2001/XMLSchema#string

P932

5776746

http://www.w3.org/2001/XMLSchema#string